In patients with gastric and hepatocellular carcinomas, the levels of EPO/EPOR correlate with angiogenesis and tumor progression; therefore, EPO might serve as an endogenous stimulant of vessel growth by an autocrine and/or paracrine loop. Here, EPOR is linked to neoplasm.